Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis

Journal article

Peer reviewed

Olof Johnell, Wim H Scheele, Yili Lu, Jean-Yves Reginster, Allan G Need and Ego Seeman

The journal of clinical endocrinology and metabolism, Vol.87(3), p.92

2002

Abstract

Aged

Alendronate: therapeutic use

Biological Markers: blood

Bone Density: drug effects

Bone Remodeling: drug effects

Bone Remodeling: physiology

Clinical Medicine

Collagen: antagonists & inhibitors

Double-Blind Method

Drug Synergism

Female

Femur Neck: drug effects

Femur Neck: physiopathology

Human

Klinisk medicin

Lumbar Vertebrae: drug effects

Lumbar Vertebrae: physiopathology

Medical and Health Sciences

Medicin och hälsovetenskap

Middle Age

Non-U.S. Gov't

Orthopedics

Ortopedi

Osteocalcin: antagonists & inhibitors

Osteoporosis

Peptides: antagonists & inhibitors

Postmenopausal: drug therapy

Postmenopausal: physiopathology

Raloxifene: therapeutic use

Selective Estrogen Receptor Modulators: therapeutic use

Support

1 Record Views

Title: Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis
Creators - without role: Olof Johnell - Orthopedics - Clinical and Molecular Osteoporosis Research
Wim H Scheele
Yili Lu
Jean-Yves Reginster
Allan G Need
Ego Seeman
Publication Details: The journal of clinical endocrinology and metabolism, Vol.87(3), p.92
Identifiers: 9952847908331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article